mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |
mRNA |
OSU-03012 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.077 |
0.03 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.03 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |